Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Jesse Schulman who wrote (899)	9/9/1999 2:27:00 PM
From: arnie h	Read Replies (1) \| Respond to of 1386

<PARS results early next year - cohort 3 enrollment finished mid-summer, then six months post-treatment evaluation... add some time to crunch the numbers and pick a good forum... and you're into 2K.> ITSS: Timetable seems a bit disappointing and there appears to be a lot more riding on the outcome than what might normally be expected from a Phase 2. If Phase 2 has taken this long, one can imagine how long it would take the company to do Phase 3 if going it alone. Even us long term investors might get a bit discouraged unless the ophthalmology products can carry the company into higher ground. Thanks for the info. Arnie